Immune response to two-dose fractional inactivated poliovirus vaccine administered at 4- and 8- month of age
Immune response and seroconversion in two-dose fractional inactivated poliovirus vaccine administered at 4 and 8 months of age
World Health Organization
320 participants
Jul 1, 2009
Interventional
Conditions
Summary
The purpose of this study is to test the efficacy of a two dose schedule using either fractional or full dose IPV with the ultimate purpose to find a way for developing countries to adopt more affordable IPV use strategies in the future. It is hypothesized the fractional dose arm will be non-inferior to the full dose arm.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Two fractional 0.1 ml IPV doses administered intradermally at 4 and 8 month old infants
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12610001046099